Market Signal Briefing

Nigeria has established a working group to explore the possible adoption of stablecoins as part of ongoing efforts to support innovation in the financial sector. According to Olayemi Cardoso, governor of the Central Bank of Nigeria (CBN), the development comes amidst plans to balance the risks of emerging technologies.

Ethereum enthusiasts witnessed a major treasury move this week as BitMine Immersion Technologies acquired 104,336 ETH, worth roughly $417 million, during a recent market dip. On-chain data shows that the purchase occurred across three new wallet addresses via Kraken and BitGo, highlighting continued institutional accumulation despite a subdued market.

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Ripple CTO David Schwartz has recently addressed a misconception about XRP Ledger's UNL. A unique node list (UNL) refers to a server's list of trusted validators.

An X user said in a tweet that he was unable to change trusted validators in his public XRP-GUI wallet, indicating that he was looking to use a UNL outside that provided by Ripple. He also posed the question, "99% of the population is reliant on the UNL that Ripple publishes, what is stopping them from manipulating the UNL?"

The UNL affects the way the network makes forward progress. Wallets just observe that. And manipulating the UNL to do what? If nodes don't agree with the validators on their UNL, the network halts.

HOT Stories

— David 'JoelKatz' Schwartz (@JoelKatz) October 18, 2025 This tweet attracted a response from Ripple CTO David Schwartz, who clarified the essence of UNL to the XRPL network. Schwartz responded that UNL affects the way the network makes forward progress, and wallets also observe this, answering the X user's question of why trusted validators could not be changed.

Squashing concerns about a potential network manipulation, Schwartz added that if nodes do not agree with the validators on their UNL, the network halts.

Every XRP Ledger server is natively configured with a UNL, which determines which validation votes it listens to and which votes it throws out during the consensus process.

Why it mattersEach server operator has full control over which validators are included in their UNL.

However, if two servers operate with totally different UNLs, they are likely to reach different conclusions about when ledgers (and the transactions in them) are validated. This could cause a fork in the network with parties on different sides unable to mutually agree and transact with one another.

To avoid forking, servers on XRP Ledger are required to be configured with UNLs that have a high degree of overlap with one another.

To make it easier to get a different and reliable list of validators that has high overlap with others, XRP Ledger utilizes a system of recommended validator lists. Currently, the default configuration for XRP Ledger servers uses two lists: one published by the XRP Ledger Foundation and one published by Ripple. The term default UNL (sometimes abbreviated dUNL) refers to the set of validators included in these lists.

The crypto markets experienced a massive pullback before the weekly close that liquidated nearly $20 billion from the markets. With this, the XRP price marked lows at $1.2, levels not seen since the breakout in November 2024. Currently, XRP is trading around $2.36, reflecting a renewed phase of consolidation after recent turbulence. With multiple catalysts—chiefly the looming decisions over spot ETF applications and lingering macro risks—the token finds itself at a crucial inflexion point. 

Traders and investors alike are asking: Will XRP break higher toward the next resistance, or will a breakdown trigger a deeper correction?

The overall crypto market has cooled after a week of profit-taking and liquidity squeezes across major assets. Bitcoin’s inability to reclaim the $110,000 mark has spilt over to altcoins, with Ethereum dropping $4,000 and Solana testing $185. XRP, however, has managed to sustain relatively better stability. Its strong on-chain metrics, such as consistent wallet growth and exchange outflows, hint at a possible accumulation phase.

Regulatory and ETF DevelopmentsRegulatory clarity continues to be a critical driver for XRP’s valuation. Recent reports suggest that institutional lobbyists have intensified efforts to push for the first spot XRP ETF, following the success of Bitcoin and Ethereum ETFs. If approved, this could open the floodgates for traditional investment funds to enter the XRP ecosystem—a move that could drastically impact liquidity and price discovery.

Ripple Labs has also strengthened its global footprint by expanding payment partnerships across the Middle East and Latin America, reaffirming the XRP Ledger’s utility in real-world settlements. Such developments build long-term credibility even amid short-term market fluctuations.

Besides, On-chain data from Santiment reveals a surge in transactions exceeding $1 million, a pattern often linked to institutional rebalancing or early-stage accumulation. Additionally, exchange reserves have declined by nearly 5% over the past week—signaling that investors are moving tokens into cold storage, a historically bullish sign.

Price Forecast ScenariosBullish Case: If XRP manages a confirmed breakout above $2.90, a strong rally could follow, targeting $3.60–$3.80 as the next resistance band. A decisive weekly close above $4 would invalidate the long-term bearish trend and open doors toward $5, driven by ETF optimism and renewed retail participation.

Neutral Case: In the event of prolonged consolidation between $2.20 and $2.90, XRP may remain range-bound until a macro or regulatory trigger provides directional clarity. This scenario would likely persist until mid-November as liquidity builds within the triangle formation.

Bearish Case: Failure to hold the $2.20 support could accelerate a downside move toward $1.90, where the 200-day MA sits. A close below this level would confirm a bearish breakdown, potentially resetting the structure and delaying any bullish continuation into Q4.

Investor Sentiment & Key RisksMarket sentiment toward XRP is cautiously positive, with traders awaiting confirmation of both regulatory updates and on-chain follow-through. However, the lack of immediate catalysts could limit upside momentum in the short term.

Key risks include:

Regulatory delays or ETF rejections.Broader crypto market weakness due to macroeconomic tightening.Profit-taking by large holders after short-term rallies.Still, the overall tone remains constructive as XRP continues to attract institutional attention and showcase expanding network utility.

ConclusionXRP stands at a pivotal crossroads—technical indicators point to stabilization, while fundamentals signal growing institutional confidence. The $2.20–$2.90 range remains crucial for determining its next move. A bullish breakout above resistance could position XRP for a sustained uptrend toward $4, while a breakdown below support might reignite short-term bearish sentiment.

With volatility compressing and on-chain signals improving, XRP’s next decisive move could set the tone for its Q4 performance and potentially the broader altcoin market.

Trust with CoinPedia:CoinPedia has been delivering accurate and timely cryptocurrency and blockchain updates since 2017. All content is created by our expert panel of analysts and journalists, following strict Editorial Guidelines based on E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). Every article is fact-checked against reputable sources to ensure accuracy, transparency, and reliability. Our review policy guarantees unbiased evaluations when recommending exchanges, platforms, or tools. We strive to provide timely updates about everything crypto & blockchain, right from startups to industry majors.

Investment Disclaimer:All opinions and insights shared represent the author's own views on current market conditions. Please do your own research before making investment decisions. Neither the writer nor the publication assumes responsibility for your financial choices.

Sponsored and Advertisements:Sponsored content and affiliate links may appear on our site. Advertisements are marked clearly, and our editorial content remains entirely independent from our ad partners.

After briefly taking on a structure suggesting an imminent recuperation from the October 10 market downturn, the Bitcoin price appears to be heading into the weekend with a clear bearish outlook. According to data from recent on-chain analysis, the world’s largest cryptocurrency still faces an even higher risk of increased bearish pressure, which may lead to a deeper correction over the next few weeks.

Binance Records Daily High Of 40 BTC Inflows
In an October 17 post on the social media platform X, pseudonymous on-chain analyst Darkfost revealed a shift in the behavior of market participants within Bitcoin’s oldest investor class.

In the post on X, the analyst referenced results from the Binance Exchange Inflow — Spent Output Age Bands metric, which tracks the amount of Bitcoin sent to Binance, and the age of these coins being sent out. In this case, transactions from the long-term holders (based on their age) were tracked.

Darkfost explained that the 7-day Moving Average (MA) of these BTC inflows on Binance has seen a rise to 40 BTC per day within just a short period of time. What’s more interesting is that the 7-day MA jumped from around 4 BTC per day to this local high.

When compared to previous levels, a sudden rise to about 40 Bitcoins per day could be significant news for the world’s leading cryptocurrency.

What This Means For Bitcoin Price
Because Bitcoin’s long-term holders hold more than 80 percent of its total supply, their actions across exchanges tend to heavily affect price volatility. Darkfost further explained how recent LTH activity could affect market dynamics.

Backed by historical occurrences, the analyst made it clear that increasing inflows of BTC to Binance also point to a potential increase in selling pressure; this is because transfers to exchanges are often associated with selling activity, as they act as mediums for quick sell-offs or profit-taking.

When long-term holders begin moving their holdings to exchanges, they are known to move them in large quantities, and evidently not without intent. Interestingly, the surge in Binance inflows preceded LTH profit taking — an event which ignited the most recent crash seen by the Bitcoin market, and the simultaneous reintegration into market supply of “ancient BTC.”

Source: @Darkfost_Coc on X
From the chart shared by Darkfost, the inflow levels seem to be maintaining fairly good levels. While this might be good in the short term, the analyst advised that it would be best to watch out for its upward trend. “Should it continue to accelerate, it could indicate a shift in LTH positioning and potentially mark the beginning of a short-term distribution phase,” the analyst added.

As of press time, Bitcoin is valued at approximately $107,085, reflecting an almost 2% decline in the past day.

The price of BTC on the daily timeframe | Source: BTCUSDT chart on TradingView
Featured image from iStock, chart from TradingView

The Bitcoin price has crashed into a correction after plunging by 14% from its highest point this year, and the trend may continue as a risky pattern forms and exchange-traded fund (ETF) outflows persist. 

Summary

Bitcoin price has formed a double-top pattern on the daily chart.
Spot Bitcoin ETFs shed over $1.6 billion in assets this week.
Investors are experiencing significant concerns following the recent liquidations.

American investors dumped their Bitcoin (BTC) holdings this week as the crypto Fear and Greed Index plummeted into the fear zone and liquidations surged. 

Data compiled by SoSoValue shows that spot Bitcoin ETFs shed over $1.23 billion in assets this week. BlackRock’s IBIT shed over $268 million, while Fidelity’s FBTC lost 

These outflows brought the cumulative inflows since their inception in January last year to $61.54 billion. 

The outflows represented a sharp reversal from the previous two weeks, during which they had added almost $6 billion in assets.

Investors dumped Bitcoin after it suffered over $4.65 billion in liquidations last Friday, as the crypto market crashed. It is common for investors to sell their coins or stay in the sidelines after such a big liquidation event. 

Bitcoin liquidations peaked at $4.65 billion last week | Source: CoinGlass
They also sold Bitcoin as gold emerged as a better safe-haven asset amid rising risks. There are risks that the trade war between the US and China will escalate, leading to higher inflation, which may prevent the Fed from cutting interest rates. 

The other notable risks include the ongoing U.S. government shutdown and credit quality. Credit issues emerged after three regional banks reported fraud-related losses. 

Bitcoin price technical analysis
BTC price chart | Source: crypto.news
The daily timeframe chart shows that the BTC price remains under pressure after falling by 14% from its highest point this year. 

It has crashed below the 50-day moving average, while the Supertrend indicator has turned red. Most notably, the coin has formed a double-top pattern at $124,355. 

A double top is one of the most common bearish signs in technical analysis. Its profit target is estimated by measuring the distance between the head and the neckline, and then the same one from the neckline. 

In this case, the profit target is about $92,345, its lowest point since April this year. A move above the resistance level at $113,000 will invalidate the bearish outlook.

Jupiter launches Ultra v3 on Solana, boosting trade execution, slippage control, and gasless swaps with 100x performance gains.

Izabela Anna2 min read

18 October 2025, 04:08 PM

Solana-based decentralized exchange aggregator Jupiter has launched Ultra v3, its most advanced trading engine designed to improve trade execution, minimize slippage, and offer gasless transactions. 

The upgrade aims to make decentralized trading on Solana faster, more reliable, and accessible to all users. Ultra v3 integrates new routing algorithms, enhanced MEV protection, and predictive execution models to deliver precise on-chain outcomes rather than simulated quotes.

Advanced Routing and Execution EnhancementsUltra v3 introduces Iris, a new router that replaces the older Metis system. The router supports better order splitting up to 0.01% accuracy and employs refined routing algorithms like Golden-section and Brent’s method. 

Consequently, performance and efficiency have improved by nearly 100 times compared to previous versions. The engine’s Predictive Execution feature prioritizes realistic on-chain results by forecasting slippage and dynamically choosing optimal routes, ensuring traders receive the best available price at execution.

Additionally, Ultra v3 includes ShadowLane, Jupiter’s proprietary transaction landing engine. The system reduces latency from three blocks to under one, allowing trades to settle within milliseconds. 

This design eliminates the need for third-party relays, protecting users from harmful MEV practices. According to Jupiter’s internal benchmarks, the new protocol offers 34 times better sandwich protection and up to ten times lower execution fees than competing decentralized platforms.

Enhanced Protections and Gasless SupportSecurity and accessibility are central to Ultra v3’s design. The new Real-Time Slippage Estimator (RTSE) automatically adjusts acceptable price ranges during volatile conditions. This feature minimizes failed transactions and ensures that traders do not overpay for slippage. 

Besides, the upgraded Gasless Support allows users to execute trades without holding SOL for fees. As long as one traded token meets the qualifying value, Jupiter covers the gas from the swap itself.

Moreover, Ultra v3 introduces Ultra Signaling to help Prop AMMs identify non-toxic traders, enabling them to quote up to 50% tighter spreads. The system’s Just-In-Time Market Revival further expands liquidity by routing trades through previously inactive markets.

Solana Price OutlookSource: X

Meanwhile, Solana’s native token, SOL, is trading around $185, marking a 3.6% daily gain. Market analyst Ali Martinez noted that SOL is consolidating above the $180 support zone. A breakout above $191 could confirm renewed bullish momentum toward $210. Hence, sustained buying activity around current levels could strengthen confidence in Solana’s broader ecosystem recovery.

ENRICH your inbox with our best storiesDon’t miss out and join our newsletter to get the latest,
well-curated news from the crypto world!

Izabela Anna

Izabela Anna is a knowledgeable freelance journalist, who boasts over five years of experience covering the cryptocurrency market. Her tenure has seen her navigate through the ebbs and flows of multiple market cycles, giving her a deep understanding within. Her journalistic focus lies in dissecting price action dynamics, scrutinizing the on-chain landscape, and providing insights from a technical perspective, making her a trusted voice in the realm of cryptocurrency reporting.

Read more about

Latest Solana (SOL) News Today

Why Trust CoinGape

CoinGape has covered the cryptocurrency industry since 2017, aiming to provide informative insights to our readers. Our journal analysts bring years of experience in market analysis and blockchain technology to ensure factual accuracy and balanced reporting. By following our Editorial Policy, our writers verify every source, fact-check each story, rely on reputable sources, and attribute quotes and media correctly. We also follow a rigorous Review Methodology when evaluating exchanges and tools. From emerging blockchain projects and coin launches to industry events and technical developments, we cover all facets of the digital asset space with unwavering commitment to timely, relevant information.

A leading crypto analyst has identified what he calls a “historic opportunity” for investors to shift from gold to Bitcoin (BTC). Joao Wedson, a verified author at CryptoQuant, said bottom signals in the BTC/Gold ratio are flashing strongly. This suggests a potential turning point in the long-term relationship between the two assets.

Rare Bitcoin/Gold Bottom Signals Hint at Strong Reversal Potential
The Wedson post explained that these bottom signals rarely appear. When they do, they often emerge during periods of extreme volatility and steep Bitcoin drawdowns.

According to him, such conditions tend to mark significant lows that historically precede powerful Bitcoin recoveries. This sentiment aligns with a recent analysis by former BitMEX CEO Arthur Hayes. Hayes argued that the current Bitcoin price represents a major buying opportunity.

“We’re exactly there right now,” he said, describing the current market setup as one of the most compelling in recent years. The chart presented by Wedson displays 2 signals with blue and green tags. The blue signal indicates the current bottom in the BTC/Gold ratio, revealed through a normalized oscillator.

The oscillator, he said, is “basically screaming: time to sell gold and buy Bitcoin.” The green signal is even more powerful, appearing when both indicators align at their lows. Historically, this alignment has marked some of the best Bitcoin buying opportunities ever recorded against gold.

This chart by Joao Wedson highlights bottom indicators in the BTC/Gold ratio, signaling a possible trend reversal favoring Bitcoin.
BTC/Gold Ratio Shows Shift in Institutional Investment
Wedson added that his analysis applies particularly to institutional investors that have been piling up gold in recent times. He urged them to reconsider their allocation strategies, arguing that Bitcoin now presents a stronger risk-reward profile. “If I were you, I’d take a close look at this chart,” he said.

The BTC/Gold ratio has historically acted as a barometer of investor confidence between the two assets. The long-running gold versus Bitcoin debate resurfaced recently after economist Peter Schiff claimed that Bitcoin has failed as digital gold. Binance’s CZ quickly rejected the assertion, defending Bitcoin’s long-term value and resilience.

When the ratio bottoms out, it often signals the end of Bitcoin’s underperformance and the start of a new bullish phase. Past examples include cycles where Bitcoin later surged to new all-time highs within months.

Bitcoin Trades in Deep Value Zone
Adding to the optimism, crypto outlet Milk Road said Bitcoin is now trading two standard deviations below its ideal range. According to them this is a sign that it could be entering a deep value zone.

The platform noted that such conditions have historically coincided with major accumulation phases, not market tops. “It might be one of the best buying opportunities for Bitcoin,” the post read, emphasizing that macro trends still point to a bull run continuing into 2026.

This chart highlights Bitcoin’s position near its lower trendline, signaling a potential accumulation zone for long-term investors.
At press time, BTC price was around $106,925, up 0.42% in the last 24 hours, according to TradingView data. Despite recent volatility, the leading cryptocurrency remains up 14.6% year-to-date.

Also, it has gained nearly 59% over the past year. The publication reminded investors of a timeless principle in volatile markets: “Be greedy when others are fearful.”

Investment disclaimer: The content reflects the author’s personal views and current market conditions. Please conduct your own research before investing in cryptocurrencies, as neither the author nor the publication is responsible for any financial losses.

Ad Disclosure: This site may feature sponsored content and affiliate links. All advertisements are clearly labeled, and ad partners have no influence over our editorial content.

Original U.Today article

Sat, 18/10/2025 - 16:35

Can the rate of Ethereum (ETH) return above $4,000 next week?

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

The prices of most coins are rising on the first day of the weekend, according to CoinStats.

ETH chart by CoinStatsETH/USDThe rate of Ethereum (ETH) has gone up by 3.49% over the last 24 hours.

Image by TradingViewOn the hourly chart, the price of ETH is in the middle of the local channel between the support of $3,819 and the resistance of $3,927.

You Might Also Like

As the rate of the main altcoin is far from the main levels, there are no chances to see sharp moves by tomorrow.

On the bigger time frame, the picture is more bearish than bullish. The rate of ETH is closer to the support than to the resistance level. If a breakout of the $3,694 mark happens, the correction is likely to continue to the $3,500 range.

Image by TradingViewFrom the midterm point of view, neither bulls nor bears are dominating. In this case, traders should focus on the interim zone of $4,000. If a breakout happens, the accumulated energy might be enough for a more profound correction to the $3,000-$3,200 area.

Ethereum is trading at $3,872 at press time.

Related articles

Original U.Today article

Sat, 18/10/2025 - 16:49

Can traders expect Bitcoin (BTC) to test the $100,000 mark next week?

Cover image via U.Today

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

Buyers are trying to seize the initiative on Saturday, according to CoinStats.

Top coins by CoinStats BTC/USDThe rate of Bitcoin (BTC) has risen by 1.11% since yesterday.

Image by TradingViewOn the hourly chart, the price of BTC is far from the support and resistance levels. The volume is low, which means traders are unlikely to witness increased volatility by tomorrow.

Image by TradingViewOn the bigger time frame, there are no reversal signals so far. In this regard, one should pay attention to yesterday's bar low of $103,530.

You Might Also Like

If bulls lose it, the decline may continue to the $100,000 area.

Image by TradingViewFrom the midterm point of view, sellers are also more powerful than buyers. If a breakout of the $100,426 support happens, the accumulated energy might be enough for a move to the $95,000 zone.

Bitcoin is trading at $106,909 at press time.

Related articles

North Korean threat actors have adopted a blockchain-based technique called EtherHiding to deliver malware designed to steal cryptocurrency including XRP.

Summary

Hackers embed malicious code in smart contracts to steal XRP and other crypto.
EtherHiding evades takedowns by hosting malware on decentralized blockchains.
Fake recruiters trick developers into installing malware during job interviews.

According to Google’s Threat Intelligence Group, this is the first time GTIG has observed a nation-state actor using this method.

The method embeds malicious JavaScript payloads inside blockchain smart contracts to create resilient command-and-control servers.

The EtherHiding technique targets developers in cryptocurrency and technology sectors through social engineering campaigns tracked as “Contagious Interview.”

The campaign has led to numerous cryptocurrency heists affecting XRP (XRP) holders and users of other digital assets.

Blockchain-based attack infrastructure evades detection
EtherHiding stores malicious code on decentralized and permissionless blockchains and removes central servers that law enforcement or cybersecurity firms can take down.

Attackers controlling smart contracts can update malicious payloads at any time and maintain persistent access to compromised systems.

Security researchers can tag contracts as malicious on blockchain scanners like BscScan, but malicious activity continues regardless of these warnings.

Google’s report describes EtherHiding as a “shift towards next-generation bulletproof hosting” where blockchain technology features enable malicious purposes.

When users interact with compromised sites, the code activates to steal XRP, other cryptocurrencies, and sensitive data.

The compromised websites communicate with blockchain networks using read-only functions that avoid creating ledger transactions. This minimizes detection and transaction fees.

Sophisticated social engineering
The Contagious Interview campaign centers on social engineering tactics that mimicks legitimate recruitment processes through fake recruiters and fabricated companies.

Fake recruiters lure candidates onto platforms like Telegram or Discord, then deliver malware through deceptive coding tests or fake software downloads disguised as technical assessments.

The campaign employs multi-stage malware infection, including JADESNOW, BEAVERTAIL, and INVISIBLEFERRET variants affecting Windows, macOS, and Linux systems.

Victims believe they’re participating in legitimate job interviews while unknowingly downloading malware designed to gain persistent access to corporate networks and steal cryptocurrency holdings.

19h30 ▪
4
min read ▪ by
Fenelon L.

Summarize this article with:

DeFi Development Corp. has just reached a new milestone. The Nasdaq-listed company has injected an additional 16 million dollars into its Solana reserves, thus consolidating its position among the largest institutional holders of the SOL crypto.

In brief

DeFi Development Corp. has just acquired 86,307 additional SOL tokens for 16 million dollars, at an average price of $110.91 per unit.
The company’s total reserves now exceed 2 million SOL, valued at around 426 million dollars.
This operation positions DeFi Development among the top five largest public Solana holders, although Forward Industries maintains the top spot with nearly 7 million tokens.

Development continues to invest massively in Solana
DeFi Development Corp. does not hide its ambitions. The company listed under the ticker DFDV has just announced the acquisition of 86,307 SOL tokens bringing its holdings to more than 2 million tokens. 

This operation, carried out at an average price of 110.91 dollars per unit, represents an investment of 16 million dollars and increases the company’s reserves by nearly 5%.

This massive accumulation strategy recalls that of MicroStrategy with bitcoin, but applied to the Solana ecosystem. The company founded this year by former Kraken executives is betting everything on the blockchain known for its speed and low fees.

With about 28 million shares outstanding, DeFi Development now displays a ratio of 14.67 dollars of SOL per share, a figure down from the 19.44 dollars recorded in September when the company had 25 million shares.

This dilution of shares raises questions. Investors must wonder whether this rapid expansion of the share capital may dilute value for existing shareholders, despite the increase in SOL reserves. 

A unique positioning but fierce competition
DeFi Development does not just buy and hold tokens. The company also deploys a staking strategy on various assets within the Solana ecosystem, including memecoins like Dogwifhat. 

It also generates additional revenue through its validation services, notably for Kraken, the crypto exchange from which its founders come.

This diversification of activities is an undeniable asset. By combining reserve accumulation and operational revenue generation, DeFi Development aims to create a more resilient business model than simple “treasury companies” that only hold cryptos.

However, competition remains fierce. While DeFi Development ranks among the top five largest public Solana holders, it is still far from Forward Industries (ticker FORD), the undisputed leader. 

This company, backed by heavyweights like Galaxy, Jump Crypto, and Multicoin Capital, holds nearly 7 million SOL. A figure that alone exceeds the combined reserves of the next three companies.

This domination by Forward Industries raises a crucial question: can the market support several large “Solana treasuries” without causing excessive concentration? The answer will likely determine the long-term success of companies like DeFi Development.

DeFi Development continues its aggressive accumulation of Solana but navigates still uncharted waters. While the strategy may pay off if the SOL price soars, it also exposes the company to the inherent risks of crypto volatility.

Only the future will tell if this bold bet will turn DeFi Development into a major player in the blockchain economy or simply a victim of an unpredictable market.

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

Fenelon L.

Passionné par le Bitcoin, j'aime explorer les méandres de la blockchain et des cryptos et je partage mes découvertes avec la communauté. Mon rêve est de vivre dans un monde où la vie privée et la liberté financière sont garanties pour tous, et je crois fermement que Bitcoin est l'outil qui peut rendre cela possible.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.

NEW YORK, Oct. 18, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

TrueCar, Inc. (NASDAQ: TRUE)’s sale to Fair Holdings, Inc., an entity led by TrueCar founder Scott Painter, for $2.55 per share. If you are a TrueCar shareholder, click here to learn more about your legal rights and options.

Hillenbrand, Inc. (NYSE: HI)’s sale to an affiliate of Lone Star Funds for $32.00 per share in cash. If you are a Hillenbrand shareholder, click here to learn more about your rights and options.

Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
One World Trade Center
85th Floor
New York, NY 10007
(212) 763-0060
[email protected]
[email protected]  
https://www.halpersadeh.com

Analyst’s Disclosure:I/we have a beneficial long position in the shares of T.PR.C either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

I am also writing (out of the money) put options on AT&T.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

On October 17, 2025, Oak Harvest Investment Services, a division of Oak Harvest Financial Group, disclosed a new position in Verizon Communications (VZ 0.48%), acquiring shares valued at approximately $10.7 million in Q3 2025.

IMAGE SOURCE: VERIZON.

What happenedAccording to a filing with the U.S. Securities and Exchange Commission dated October 17, 2025, Oak Harvest Investment Services initiated a new position in Verizon Communications, purchasing approximately 243,369 shares. The estimated transaction value, based on the average price in Q3 2025, was $10.7 million. As this was an initial investment, Oak Harvest's reported total holdings in Verizon were also $10.7 million.

What else to knowThis new position accounts for 1.2% of Oak Harvest Investment Services' $857.35 million in 13F reportable assets as of September 30, 2025, placing it outside the top five holdings.

Top holdings after the filing:

VGSH: $51.76 million (6.0% of AUM) as of September 30, 2025VOO: $44.57 million (5.2% of AUM) as of September 30, 2025AAPL: $34.54 million (4.0% of AUM) as of September 30, 2025VYM: $25.39 million (3.0% of AUM) as of September 30, 2025JPM: $23.36 million (2.7% of AUM) as of September 30, 2025As of October 17, 2025, Verizon Communications shares were priced at $40.55, down 7.8% over the past year, underperforming the S&P 500 by 21.6 percentage points during the same period.

Company OverviewMetricValueRevenue (TTM)$137.00 billionNet Income (TTM)$18.19 billionDividend Yield6.81%Price (as of market close October 17, 2025)$40.55Company SnapshotVerizon Communications is a leading provider of telecommunications and technology services with a diversified portfolio spanning consumer and business segments. The company leverages its extensive network infrastructure to deliver connectivity, digital services, and managed solutions at scale.

The company provides wireless and wireline communications, internet access, video, voice services, and network solutions to consumers, businesses, and government entities worldwide.

Verizon generates revenue through subscription-based service plans, equipment sales, and network access fees from both consumers and business clients.

Foolish takeOak Harvest Investment Services buying Verizon shares is noteworthy because of its decision to begin a position in the beleaguered stock. A confluence of factors could be driving the decision to invest in the telecommunications giant at this time.

Despite tough competition in the industry, Verizon grew Q2 revenue by 5% year over year to $34.5 billion. The company also ended the first half of 2025 with free cash flow (FCF) of $8.8 billion, an increase from 2024's $8.5 billion.

This led Verizon to raise its FCF outlook for the year to between $19.5 billion to $20.5 billion. FCF is a key factor in the company's ability to pay its robust dividend.

Speaking of which, the dividend could have been another contributor to Oak Harvest taking a stake in Verizon. After all, the yield is currently an impressive 6.8%.

The juicy dividend yield combines with Verizon's attractive price-to-earnings ratio of around 9 to make the company's stock a compelling investment. These factors also mean it's a good time to buy Verizon shares, especially for income investors.

Glossary13F reportable assets: Assets that investment managers must disclose quarterly to the SEC if they exceed a certain threshold.
Assets under management (AUM): The total market value of investments managed on behalf of clients by a financial institution or fund.
Position: The amount of a particular security or asset held by an investor or fund.
Stake: The ownership interest or share held in a company or asset.
Dividend Yield: A financial ratio showing how much a company pays in dividends each year relative to its stock price.
Top holdings: The largest investments in a fund or portfolio, typically ranked by value or percentage of total assets.
Subscription-based service plans: Recurring payment models where customers pay regularly for ongoing access to a service.
TTM: The 12-month period ending with the most recent quarterly report.

JPMorgan Chase is an advertising partner of Motley Fool Money. Robert Izquierdo has positions in Apple, JPMorgan Chase, and Verizon Communications. The Motley Fool has positions in and recommends Apple, JPMorgan Chase, Vanguard S&P 500 ETF, and Vanguard Whitehall Funds - Vanguard High Dividend Yield ETF. The Motley Fool recommends Verizon Communications. The Motley Fool has a disclosure policy.

NEW YORK, Oct. 18, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 8, 2025.

SO WHAT: If you purchased aTyr Pharma common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the aTyr Pharma class action, go to https://rosenlegal.com/submit-form/?case_id=46109 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 8, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the complaint, defendants provided overwhelmingly positive statements to investors while, at the same time, disseminating false and misleading statements and/or concealing material adverse facts concerning the efficacy of Efzofitimod, particularly, the drug’s capability to allow a patient to completely taper their steroid usage. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the aTyr Pharma class action, go to https://rosenlegal.com/submit-form/?case_id=46109 call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Johnson & Johnson Today

JNJ

Johnson & Johnson

$193.26 +1.15 (+0.60%)

As of 10/17/2025 03:59 PM Eastern

This is a fair market value price provided by Polygon.io. Learn more.

52-Week Range$140.68▼

$194.40Dividend Yield2.69%

P/E Ratio18.65

Price Target$199.59

Recent market speculation linking Johnson & Johnson NYSE: JNJ to a complete acquisition of its partner, Protagonist Therapeutics NASDAQ: PTGX, offers a valuable glimpse into a core corporate strategy. For a healthcare sector giant of Johnson & Johnson's scale, such moves are not about chasing short-term stock pops. They are a fundamental part of a long-term playbook designed to systematically acquire innovation, fuel future growth, and deliver reliable shareholder value.

Understanding this disciplined strategy is key to understanding the company’s future and why many investors are looking past near-term headwinds.

Get Johnson & Johnson alerts:

Trimming the Fat, Fueling the Future
The foundation of Johnson & Johnson’s acquisition strategy is an active and continuous reshaping of its entire portfolio. This is more than buying new companies; it is about strategically divesting slower-growth assets to unlock capital and management focus for redeployment into higher-growth opportunities.

The 2023 spinoff of the Kenvue NYSE: KVUE consumer health business was the first significant step. The recently announced plan to separate the Orthopedics business, a division that generated approximately $9.2 billion in 2024 sales, is the next step in the company's strategy.

This strategic pruning provides Johnson & Johnson with immense financial firepower to pursue external innovation. The company’s financial health, demonstrated by the generation of approximately $14 billion in free cash flow in the first three quarters of 2025, is fuel for its acquisition engine.

For investors, the message is clear: management is actively steering the company away from lower-margin businesses to concentrate its resources on the high-stakes, high-reward frontiers of medicine and technology.

How Recent Deals Are Already Paying Off
Johnson & Johnson’s strategy has a proven track record of delivering tangible results that are already boosting the bottom line. Recent MedTech and Innovative Medicine acquisitions show how effectively the company can identify, acquire, and integrate high-value assets to drive immediate growth.

Supercharging MedTech: The acquisitions of Abiomed and Shockwave Medical have transformed Johnson & Johnson's MedTech segment. These deals are a primary reason the Cardiovascular unit has become a standout performer, posting an impressive 11.6% operational growth in the third quarter of 2025 earnings report. This success is turning what was once a steady business into a high-growth engine, validating the company's capital deployment strategy.
Bolstering the Pharma Pipeline: The recent acquisition of Intra-Cellular Therapies brought the key asset CAPLYTA into the pharmaceutical portfolio. The drug is already a significant contributor, delivering $240 million in sales in the third quarter alone and demonstrating healthy sequential growth. Management now cites it as a primary driver for the Neuroscience franchise, showcasing how quickly an acquisition can become a core part of the growth story.

These examples demonstrate a clear pattern: Johnson & Johnson is not just making deals but making the right deals in the right markets and executing them effectively.

The J&J Method: Partner, Validate, Acquire
Johnson & Johnson Stock Forecast Today12-Month Stock Price Forecast:
$199.59
3.27% Upside

Moderate Buy
Based on 22 Analyst Ratings

Current Price$193.27High Forecast$215.00Average Forecast$199.59Low Forecast$153.00Johnson & Johnson Stock Forecast Details

The potential Protagonist acquisition is a perfect, real-time case study of the company’s disciplined M&A playbook. This is not a speculative move on an unknown technology but the logical culmination of a long-term, successful partnership.

Johnson & Johnson has collaborated with Protagonist for years to develop icotrokinra, a first-in-class oral peptide for treating immune-mediated diseases. That partnership has been exceptionally fruitful. Icotrokinra is now a significant asset in Johnson & Johnson’s late-stage pipeline, recently submitted to the FDA for approval in plaque psoriasis.

The drug has also demonstrated superiority to a key competitor, deucravacitinib, in head-to-head clinical trials and posted positive new data in ulcerative colitis.

This partner, validate, then acquire approach is a highly disciplined form of M&A that de-risks the investment for shareholders. It allows Johnson & Johnson to confirm an asset's clinical potential before committing the much larger capital required for a complete acquisition.

The rumored deal represents a strategic move to gain full ownership of a highly promising, clinically validated asset that Johnson & Johnson already knows intimately, thereby maximizing the probability of a triumphant return on investment.

Growth, Income, and a De-Risked Future
For long-term, conservative investors, Johnson & Johnson's M&A strategy is the engine that drives the company’s entire value proposition. It provides a clear and effective method for ensuring future growth and its unwavering commitment to shareholder returns.

Johnson & Johnson Dividend PaymentsDividend Yield2.69%

Annual Dividend$5.20

Dividend Increase Track Record64 Years

Dividend Payout Ratio50.19%

Next Dividend PaymentDec. 9

JNJ Dividend History

This disciplined acquisition strategy is the company's primary tool for offsetting major headwinds, like the ongoing patent cliff for its multi-billion-dollar drug, Stelara. The company creates a more durable and predictable long-term growth trajectory by consistently adding new, high-growth revenue streams through well-vetted deals. 

This confidence was echoed on the Q3 earnings call, where management stated they do not need large M&A to deliver on the high end of their growth targets, reinforcing the strength of their current pipeline and bolt-on strategy. The stock's long-term strength is further reinforced by a positive technical assessment from market analysts, who observe a sustained multi-year uptrend establishing a robust base for potential price growth.

Ultimately, this success directly funds Johnson & Johnson's coveted Dividend King status. The strong cash flows generated by these successfully integrated acquisitions enable the company to fund its annual $5.20 per share dividend and deliver 64 consecutive years of increases.

For income-focused investors who are eyeing the company's attractive 2.73% yield, the M&A playbook is the engine that secures the dividend's future, ensuring the company remains a cornerstone of a stable, long-term portfolio.

Should You Invest $1,000 in Johnson & Johnson Right Now?Before you consider Johnson & Johnson, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson & Johnson wasn't on the list.

While Johnson & Johnson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

CHENNAI, India, Oct. 18, 2025 (GLOBE NEWSWIRE) -- Sify Technologies Limited (NASDAQ: SIFY), India’s leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today announced that it will report its unaudited IFRS financial results for the second quarter ended September 30, 2025 on Saturday, October 25, 2025 before the market opens. 

The following Monday, October 27, 2025, Sify will host a conference call at 8:30 AM ET with Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director & Group CFO. Interested parties may participate by dialling +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-0011 (International), which will also be simultaneously broadcast live over the Internet at www.sifytechnologies.com/investors or https://www.webcaster4.com/Webcast/Page/2184/53133.

Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast.

The online archive of the Webcast will be available shortly after the conference call. Investors can also listen to the replay by dialling +1-877-481-4010 (Toll Free in the U.S. or Canada) or +1-919-882-2331 (International) and entering the replay passcode 53133. Please allow for some time post conference call to access the archive of the Webcast. The replay is available until November 03, 2025.

About Sify Technologies

A multiple times Golden Peacock award winner for Corporate Governance, Sify Technologies is India’s most comprehensive ICT service & solution provider. With Cloud at the core of our solutions portfolio, Sify is focussed on the changing ICT requirements of the emerging Digital economy and the resultant demands from large, mid and small-sized businesses. 

Sify’s infrastructure comprising state-of-the-art data centers, the largest MPLS network, partnership with global technology majors and deep expertise in business transformation solutions modelled on the cloud, make it the first choice of start-ups, SMEs and even large Enterprises on the verge of a revamp.

More than 10000 businesses across multiple verticals have taken advantage of our unassailable trinity of Data Centers, Networks and Security services and conduct their business seamlessly from more than 1700 cities in India. Internationally, Sify has presence across North America, the United Kingdom and Singapore.

Sify, Sify Technologies, Sify Infinit Spaces and Sify Digital Services are registered trademarks of Sify Technologies Limited.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements contained herein are subject to risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Sify undertakes no duty to update any forward-looking statements.

For a discussion of the risks associated with Sify’s business, please see the discussion under the caption “Risk Factors” in the company’s Annual Report on Form 20-F for the year ended March 31, 2025, which has been filed with the United States Securities and Exchange Commission and is available by accessing the database maintained by the SEC at www.sec.gov, and Sify’s other reports filed with the SEC.

For further information, please contact:

AstraZeneca's (AZN) Enhertu could help some breast cancer patients avoid surgery, according to a study unveiled Saturday at the European Society of Medical Oncology conference in Berlin.

That's the takeaway from Destiny-Breast11, one of several studies AstraZeneca presented. Patients with early-stage breast cancer were given Enhertu or a chemo cocktail. Enhertu works by sending toxic chemicals directly to the HER2 protein. HER2 shows up almost exclusively on cancer cells.

At the end of the study, more than 67% of Enhertu recipients showed no molecular signs of cancer in a tissue sample. That compares to roughly 56% of patients given the chemotherapy regimen. Notably, Enhertu carries fewer side effects than chemo due to how precise it is.

Treating early-stage breast cancer before it progresses is key to long-term survival, said David Fredrickson, AstraZeneca's executive vice president of oncology. Early-stage breast cancer carries a five-year survival rate of around 90%. By the advanced stages, just 30% of patients will still be alive after five years, he told Investor's Business Daily.

"So, the importance of that pathologic complete response, the importance of a high event-free survival cannot be overstated as it relates to the likelihood of being able to drive toward long-term durable outcomes," he said.

Enhertu's Powerful Sales Growth
Enhertu is one of AstraZeneca's rising oncology stars. Last year, the Daiichi Sankyo-partnered drug generated $1.98 billion in sales. Though the drug accounted for just 4% of AstraZeneca's total revenue, Enhertu sales grew 54%. That topped every other cancer drug in AstraZeneca's portfolio.

Now, the pharma giant is making a big push for Enhertu to be used in earlier-stage breast cancer patients.

In addition to the study in pre-surgery patients, AstraZeneca also laid out the results of its study called Destiny-Breast05. This tested Enhertu in patients who showed signs of cancer following surgery. Enhertu reduced the risk of cancer relapse by more than half compared to chemotherapy.

Importantly, 92% of patients given Enhertu were alive and free of invasive disease three years after receiving treatment.

Safety Profile Is Key
The safety profile, again, beat out traditional chemotherapy. Like chemotherapy, antibody drug conjugates, or ADCs, use toxic chemicals. But, while chemo is like a hammer, ADCs are like a laser. They send the toxic chemicals directly to proteins that show up on cancer cells.

That's particularly important in early-stage cancer, Fredrickson said.

"What you don't want to have is a serious adverse event that could have otherwise been avoided," he said. "And there were lower rates across multiple safety dimensions for the Enhertu arm than in others."

AstraZeneca is discussing next steps with global regulators, Fredrickson said. Both studies were Phase 3, meaning they are among the last the company will need to run to win Food and Drug Administration approval.

AstraZeneca Stock Is In A Buy Zone
AstraZeneca stock is currently lingering in a buy zone after breaking out of a lengthy cup-with-handle base with a buy point at 82.41, according to MarketSurge.

Shares have an improving IBD Digital Relative Strength Rating of 97. The RS Rating is a 1-99 measure of a stock's 12-month performance, pitted against all other stocks. Last week, AstraZeneca stock had an RS Rating of 77. Four weeks ago, the RS Rating was 52, an improvement from 30 three months ago.

Follow Allison Gatlin on X/Twitter at @AGatlin_IBD.

YOU MAY ALSO LIKE:

The FDA Just Granted Its Speediest Review Ever. Disc Medicine, Others Fly.

Trump Pledges To Cut Obesity Drug Prices. Novo Nordisk, Eli Lilly Stocks Dive.

Looking For The Next Big Stock Market Winners? Start With These 3 Steps

Find The Best Long-Term Investments With IBD Long-Term Leaders

Join IBD Live For Stock Ideas Each Morning Before The Open

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the first presentation of results from the pivotal Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, evaluating KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with chemotherapy (paclitaxel) with or without bevacizumab for the treatment of patients with platinum-resistant recurrent ovarian cancer. These late-breaking data will be presented today during.

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of HOM.U:CA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Nutex (NUTX) To Contact Him Directly To Discuss Their Options

If you purchased or acquired securities in Nutex between August 8, 2024 and August 14, 2025and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.

Click here to participate in the action.

NEW YORK, Oct. 18, 2025 (GLOBE NEWSWIRE) --

What’s Happening:

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ:NUTX) in the United States District Court for the Southern District of Texas on behalf of all persons and entities who purchased or otherwise acquired Nutex securities between August 8, 2024 and August 14, 2025, both dates inclusive (the “Class Period”).Investors have until October 21, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit. Allegation Details:

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) HaloMD was achieving lucrative arbitration results for Nutex by engaging in a coordinated scheme to defraud insurance companies; (ii) as a result, to the extent that they were the product of fraudulent conduct, revenues attributable to the Company's engagement with HaloMD in the IDR process were unsustainable; (iii) in addition, the Company overstated the extent to which it had remediated, and/or its ability to remediate, the material weaknesses in its internal controls over financial reporting; (iv) as a result, the Company was unable to effectively account for the treatment of certain of its stock based compensation obligations; (v) as a result, Nutex improperly calculated these stock based compensation obligations as equity rather than liabilities; (vi) the foregoing increased the risk that the Company would be unable to timely file certain financial reports with the United States Securities and Exchange Commission ("SEC"); (vii) accordingly, Nutex's business and/or financial prospects were overstated; and (viii) as a result, Defendants' public statements were materially false and misleading at all relevant times. Next Steps:

If you purchased or otherwise acquired Nutex shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at [email protected], telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you. About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Follow us for updates on LinkedIn, X, and Facebook, and keep up with other news by following Brandon Walker, Esq. on LinkedIn and X.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
[email protected]
www.bespc.com

Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Nextech3D.AI (CSE:NTAR, OTCQX:NEXCF) CEO Evan Gappelberg spoke with Proactive about how artificial intelligence (AI) is reshaping the global events industry and the company’s latest developments in delivering a fully integrated AI-powered event tech platform. 

Gappelberg said, “AI is no longer just a nice to have. It's a new operating system for the global events industry.”  

He explained that Nextech3D.ai is deploying AI to streamline event operations, from registration and ticketing to matchmaking, floor mapping, and analytics. 

The company’s recent acquisition of Eventdex, alongside integration with its existing Map D platform, forms the foundation for this system.  

Features include AI-powered business matchmaking that books attendees' calendars based on their goals and behavior, as well as a multilingual AI assistant that acts as a 24/7 digital concierge.  

The assistant provides real-time guidance and information to attendees and also serves organizers with actionable data insights. 

Wayfinding and context-aware assistance are also part of the platform, reducing the need for on-site help desks.  

Gappelberg emphasized the mission to build “the world’s most intelligent, automated event tech platform,” and noted that blockchain-based ticketing is the next area of focus. 

The rollout is beginning with existing clients from both the Eventdex and Map D platforms, with plans to expand functionality over time.